Aurora Biomed invites you to attend the 4th Annual Ion Channel Retreat: From Current Perspectives to Future
Possibilities, being held inVancouver BC, June 26-28, 2006. Our goal is to create a forum for scientific
discourse spanning the spectrum of ion channel disciplines. Researchers from both academia and industry are
invited to share knowledge for the advancement of ion channel research, drug discovery and safety pharmacology.
This year's Ion Channel Retreat was a monumental success, both in the caliber of speakers and in discussions
facilitated by the presentations. We look forward to continuing this success in 2006 and are now accepting abstracts for
podium and poster presentations in the following areas: 1) Mechanisms of Ion Channel Function, 2) Targets and Lead
Discovery, 3) Ion Channels and Safety Screening, 4) Technology and Model Systems Comparison, 5) Ion Channel
Mechanisms, and 6) New Frontiers in Ion Channel Research and Drug Discovery.
|
| Submission Information |
Deadline:
March 1, 2006
Oral / Poster presentation abstracts |
|
Contact Us:
retreat@aurorabiomed.com |
Assay and Drug Development Technologies
This peer-reviewed Medline journal will publish a special issue including
papers from the 2006 Ion Channel Retreat |
| Scientific Advisory Board |
Neil Castle
Director of Biology
Icagen Inc. |
John Dunlop
Director
Neuropharmacology & Neurophysiology
Wyeth Research |
Min Li
Department of Neuroscience &
High Throughput Screening Center
John Hopkins School of Medicine |
Tom Livelli
President & CEO
Cell & Molecular Technologies, Inc
|
Kurt Stoeckli
DI&A LG Global Head LDT
Sanofi-Aventis |
Laszlo Urban
Executive Director, PreClinical Profiling
Novartis Institute for Biomedical Research |
| 2006 Preliminary Speakers |
Manfred Auer
Novartis Leading Scientist, Innovative Screening Technologies
Novartis |
Kazimierez Babinski
Vice-President Research
Painceptor |
Neil Castle
Director of Biology
Icagen, Inc |
Gary Desir
Professor, Dept. of Internal Medicine
Yale School of Medicine |
John Dunlop
Director, Neuropharmacology and Neurophysiology
Wyeth Research |
Pau Gorostiza
Dept. of Cell and Molecular Biology
University of California, Berkeley |
Martin Gosling
Head of Laboratory, Ion Channel Pharmacology
Novartis |
Titus Kaletta
Director, Discovery and Technology Development
Devgen |
Min Li
Professor, Dept. of Neuroscience & High Throughput Biology Center
John Hopkins School of Medicine |
Istvan Nagy
Dept. of Anaesthetics and Intensive Care
Imperial College London |
Anne-Laude Perraud
Assistant Professor, Integrated Dept. of Immunology
National Jewish Medical & Research Center |
Heike Wulff
Dept. of Pharmacology
University of California, Davis |
Zhi-Gang Xiong
Director of Neurophysiology
Robert S. Dow Neurobiology Laboratories |
Zhong Zhong
Vice President, Drug Discovery Technologies
Cell & Molecular Technologies, Inc |
 |
|
